المؤلفون: Bridgewater, John, Fletcher, Peter, Palmer, Daniel H., Malik, Hassan Z., Prasad, Raj, Mirza, Darius, Anthony, Alan, Corrie, Pippa, Falk, Stephen, Finch-Jones, Meg, Wasan, Harpreet, Ross, Paul, Wall, Lucy, Wadsley, Jonathan, Evans, Thomas R., Stocken, Deborah, Stubbs, Clive, Praseedom, Raaj, Ma, Yuk Ting, Davidson, Brian, Neoptolemos, John, Iveson, Tim, Cunningham, David, Garden, O. James, Valle, Juan W., Primrose, John

المصدر: Bridgewater , J , Fletcher , P , Palmer , D H , Malik , H Z , Prasad , R , Mirza , D , Anthony , A , Corrie , P , Falk , S , Finch-Jones , M , Wasan , H , Ross , P , Wall , L , Wadsley , J , Evans , T R , Stocken , D , Stubbs , C , Praseedom , R , Ma , Y T , Davidson , B , Neoptolemos , J , Iveson , T , Cunningham , D , Garden , O ....

مصطلحات موضوعية: Adolescent, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biliary Tract Neoplasms/drug therapy, Capecitabine, Chemotherapy, Adjuvant, Humans, Prognosis, ResearchInstitutes_Networks_Beacons/mcrc, Manchester Cancer Research Centre

الاتاحة: https://research.manchester.ac.uk/en/publications/d81cbc0a-ecd3-437c-8060-6e62d0b3f1ec
https://doi.org/10.1200/JCO.21.02568
https://eprints.soton.ac.uk/455801/

المؤلفون: Voutsadakis, I.A., Kokkali, S., Digklia, A.

المصدر: Clinical colorectal cancer, vol. 23, no. 4, pp. 318-325.e1

مصطلحات موضوعية: Humans, Irinotecan/therapeutic use, Irinotecan/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Fluorouracil/therapeutic use, Fluorouracil/administration & dosage, Deoxycytidine/analogs & derivatives, Deoxycytidine/administration & dosage, Deoxycytidine/therapeutic use, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/pathology, Biliary Tract Neoplasms/mortality, Gemcitabine, Disease Progression, Progression-Free Survival, Biliary tract adenocarcinoma, CAPIRI, Cholangiocarcinoma, FOLFIRI, Second line

Relation: info:eu-repo/semantics/altIdentifier/pmid/38902137; info:eu-repo/semantics/altIdentifier/eissn/1938-0674; https://serval.unil.ch/notice/serval:BIB_B150D8B52D32

الاتاحة: https://serval.unil.ch/notice/serval:BIB_B150D8B52D32
https://doi.org/10.1016/j.clcc.2024.05.009

المساهمون: Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda, Choi, Hye Jin

مصطلحات موضوعية: Adult, Aged, Antineoplastic Agents, Immunological / administration & dosage, Immunological / adverse effects, B7-H1 Antigen / antagonists & inhibitors, B7-H1 Antigen / immunology, Biliary Tract Neoplasms / drug therapy, Biliary Tract Neoplasms / immunology, Biliary Tract Neoplasms / mortality, Female, Humans, Immunoconjugates / administration & dosage, Immunoconjugates / adverse effects, Immunoconjugates / genetics, Male, Middle Aged, Progression-Free Survival, Receptor, Transforming Growth Factor-beta Type II / genetics, Recombinant Fusion Proteins / administration & dosage, Recombinant Fusion Proteins / adverse effects, Recombinant Fusion Proteins / genetics, Signal Transduction / drug effects, Signal Transduction / immunology, Transforming Growth Factor beta / antagonists & inhibitors, Transforming Growth Factor beta / metabolism, Young Adult, gastrointestinal neoplasms, immunotherapy

Relation: JOURNAL FOR IMMUNOTHERAPY OF CANCER; J03617; OAK-2021-02662; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954; T202007285; JOURNAL FOR IMMUNOTHERAPY OF CANCER, Vol.8(1) : e000564, 2020-05

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/183954
https://doi.org/10.1136/jitc-2020-000564

المساهمون: Sarina A Piha-Paul, Do-Youn Oh, Makoto Ueno, David Malka, Hyun Cheol Chung, Adnan Nagrial, Robin K Kelley, Willeke Ros, Antoine Italiano, Kazuhiko Nakagawa, Hope S Rugo, Filippo de Braud, Andrea Iolanda Varga, Aaron Hansen, Hui Wang, Suba Krishnan, Kevin G Norwood, Toshihiko Doi, Chung, Hyun Cheol

مصطلحات موضوعية: Aged, Antibodies, Monoclonal, Humanized / adverse effects, Humanized / therapeutic use, Antineoplastic Agents, Immunological / adverse effects, Immunological / therapeutic use, B7-H1 Antigen / metabolism, Biliary Tract Neoplasms / drug therapy, Biliary Tract Neoplasms / metabolism, Female, Humans, Male, Response Evaluation Criteria in Solid Tumors, MSI-H, PD-L1, biliary tract cancer, pembrolizumab

Relation: INTERNATIONAL JOURNAL OF CANCER; J01092; OAK-2021-02525; https://ir.ymlib.yonsei.ac.kr/handle/22282913/183874; T202007190; INTERNATIONAL JOURNAL OF CANCER, Vol.147(8) : 2190-2198, 2020-10

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/183874
https://doi.org/10.1002/ijc.33013
https://onlinelibrary.wiley.com/doi/10.1002/ijc.33013

المؤلفون: Liposits, G, Arora, S P, Battisti, N M L, Soto-Perez-de-Celis, E, Loh, K P, Williams, G R

المصدر: Liposits , G , Arora , S P , Battisti , N M L , Soto-Perez-de-Celis , E , Loh , K P & Williams , G R 2023 , ' Second-line FOLFOX is not the standard of care for all patients with advanced biliary tract cancer-a commentary from the Young International Society of Geriatric Oncology ' , Annals of Oncology , vol. 34 , no. 6 , pp. 555-556 . https://doi.org/10.1016/j.annonc.2023.02.007

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Bile Duct Neoplasms, Biliary Tract Neoplasms/drug therapy, Humans, Patients, Standard of Care

Relation: https://portal.findresearcher.sdu.dk/da/publications/07742cbf-264c-484c-95ab-d03d70f02f72

الاتاحة: https://portal.findresearcher.sdu.dk/da/publications/07742cbf-264c-484c-95ab-d03d70f02f72
https://doi.org/10.1016/j.annonc.2023.02.007

المساهمون: College of Medicine, Dept. of Internal Medicine, Kyong Joo Lee, Seung Woo Yi, Jihye Cha, Jinsil Seong, Seungmin Bang, Si Young Song, Hee Man Kim, Seung Woo Park, Park, Seung Woo, Song, Si Young, Yi, Seung Woo, Bang, Seung Min, Seong, Jin Sil

مصطلحات موضوعية: Adult, Aged, Antimetabolites, Antineoplastic/administration & dosage, Antineoplastic Agents/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biliary Tract Neoplasms/diagnostic imaging, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/radiotherapy, Chemoradiotherapy/adverse effects, Chemoradiotherapy/methods, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/radiotherapy, Cisplatin/administration & dosage, Combined Modality Therapy, Common Bile Duct Neoplasms/drug therapy, Common Bile Duct Neoplasms/radiotherapy, Deoxycytidine/administration & dosage, Deoxycytidine/analogs & derivatives, Disease-Free Survival, Female, Gallbladder Neoplasms/drug therapy, Gallbladder Neoplasms/radiotherapy, Humans, Klatskin Tumor/drug therapy, Klatskin Tumor/radiotherapy, Male, Middle Aged, Pilot Projects

Relation: CANCER CHEMOTHERAPY AND PHARMACOLOGY; J00437; OAK-2016-06036; https://ir.ymlib.yonsei.ac.kr/handle/22282913/152268; https://link.springer.com/article/10.1007%2Fs00280-016-3143-2; T201604041; CANCER CHEMOTHERAPY AND PHARMACOLOGY, Vol.78(4) : 841-846, 2016

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/152268
https://doi.org/10.1007/s00280-016-3143-2
https://link.springer.com/article/10.1007%2Fs00280-016-3143-2

المساهمون: College of Medicine, Dept. of Surgery, Jung Ho Im, Jinsil Seong, Ik Jae Lee, Joon Seong Park, Dong Sup Yoon, Kyung Sik Kim, Woo Jung Lee, Kyung Ran Park, Kim, Kyung Sik, Park, Joon Seong, Seong, Jin Sil, Yoon, Dong Sup, Lee, Woo Jung, Lee, Ik Jae, Im, Jung Ho

مصطلحات موضوعية: Adult, Aged, 80 and over, Bile Ducts, Extrahepatic/drug effects, Extrahepatic/pathology, Extrahepatic/radiation effects, Extrahepatic/surgery, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/radiotherapy, Biliary Tract Neoplasms/surgery, Biliary Tract Neoplasms/therapy, Female, Humans, Male, Middle Aged, Retrospective Studies, Survival Analysis, Treatment Outcome, Adjuvant radiotherapy, Biliary tract neoplasms, Cholangiocarcinoma, Drug therapy, Extrahepatic bile duct cancer, Survival

وصف الملف: 583~595

Relation: CANCER RESEARCH AND TREATMENT; J00453; 2001~; ~2001 Journal of the Korean Cancer Research Association (���븳�븫�븰�쉶吏�); OAK-2016-01865; https://ir.ymlib.yonsei.ac.kr/handle/22282913/146733; T201601214; CANCER RESEARCH AND TREATMENT, Vol.48(2) : 583-595, 2016

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/146733
https://doi.org/10.4143/crt.2015.091

المساهمون: Seung Tae Kim, Kee-Taek Jang, Jeeyun Lee, Heung-Moon Jang, Hye-Jin Choi, Hye-Lim Jang, Se Hoon Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Joon Oh Park, Choi, Hye Jin

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/epidemiology, Biliary Tract Neoplasms/pathology, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/epidemiology, Cholangiocarcinoma/pathology, Deoxycytidine/administration & dosage, Deoxycytidine/adverse effects, Deoxycytidine/analogs & derivatives, Deoxycytidine/therapeutic use, Disease Progression, Disease-Free Survival, Erlotinib Hydrochloride, Female, Gallbladder Neoplasms/drug therapy, Gallbladder Neoplasms/epidemiology, Gallbladder Neoplasms/pathology, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Organoplatinum Compounds/administration & dosage, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/therapeutic use, Quinazolines/administration & dosage, Quinazolines/adverse effects

وصف الملف: 40~46

Relation: TRANSLATIONAL ONCOLOGY; J02752; OAK-2015-02337; https://ir.ymlib.yonsei.ac.kr/handle/22282913/141497; http://www.sciencedirect.com/science/article/pii/S1936523314001375; T201503953; TRANSLATIONAL ONCOLOGY, Vol.8(1) : 40-46, 2015

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/141497
https://doi.org/10.1016/j.tranon.2014.12.003
http://www.sciencedirect.com/science/article/pii/S1936523314001375

المساهمون: Ilkoo Noh, Hyun-Ouk Kim, Jihye Choi, Yuna Choi, Dong Ki Lee, Yong-Min Huh, Seungjoo Haam, Lee, Dong Ki, Huh, Yong Min

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/pathology, Cell Line, Tumor, Deoxycytidine/administration & dosage, Deoxycytidine/analogs & derivatives, Drug Carriers, Humans, Hyaluronan Receptors/drug effects, Nanoparticles, Paclitaxel/administration & dosage, Biliary cancer, CD44 targeting, Combined cancer therapy, Gemcitabine, Paclitaxel, Polymeric prodrug

وصف الملف: 763~774

Relation: BIOMATERIALS; J00312; OAK-2015-00998; https://ir.ymlib.yonsei.ac.kr/handle/22282913/140158; http://www.sciencedirect.com/science/article/pii/S0142961215002768; T201501503; BIOMATERIALS, Vol.53 : 763-774, 2015

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/140158
https://doi.org/10.1016/j.biomaterials.2015.03.006
http://www.sciencedirect.com/science/article/pii/S0142961215002768

المساهمون: Hee Man Kim, Kyong Joo Lee, Jihye Cha, Moon Jae Chung, Seungmin Bang, Jinsil Seong, Si Young Song, Seung Woo Park, Park, Seung Woo, Bang, Seung Min, Seong, Jin Sil, Song, Si Young, Chung, Moon Jae

مصطلحات موضوعية: Antineoplastic Agents/administration & dosage, Antineoplastic Agents/adverse effects, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/pathology, Chemoradiotherapy/methods, Disease-Free Survival, Drug Combinations, Drug Screening Assays, Antitumor, Female, Humans, Male, Middle Aged, Neoplasm Staging, Oxonic Acid*/administration & dosage, Oxonic Acid*/adverse effects, Pilot Projects, Tegafur*/administration & dosage, Tegafur*/adverse effects, Treatment Outcome, S-1, Biliary tract cancer, Concurrent chemoradiotherapy, Pilot

وصف الملف: 861~865

Relation: CANCER CHEMOTHERAPY AND PHARMACOLOGY; J00437; OAK-2014-01861; https://ir.ymlib.yonsei.ac.kr/handle/22282913/99781; http://link.springer.com/article/10.1007%2Fs00280-014-2565-y; T201403192; CANCER CHEMOTHERAPY AND PHARMACOLOGY, Vol.74(4) : 861-865, 2014

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/99781
https://doi.org/10.1007/s00280-014-2565-y
http://link.springer.com/article/10.1007%2Fs00280-014-2565-y

المساهمون: Jeeyun Lee, Se Hoon Park, Heung-Moon Chang, Jun Suk Kim, Hye Jin Choi, Myung Ah Lee, Joung Soon Chang, Hei Cheul Jeung, Jung Hun Kang, Hyun Woo Lee, Dong Bok Shin, Hye Jin Kang, Jong-Mu Sun, Joon Oh Park, Young Suk Park, Won Ki Kang, Ho Yeong Lim, Jeung, Hei Cheul, Choi, Hye Jin

مصطلحات موضوعية: Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/epidemiology, Biliary Tract Neoplasms/pathology, Cholangiocarcinoma/drug therapy, Cholangiocarcinoma/epidemiology, Cholangiocarcinoma/pathology, Deoxycytidine/administration & dosage, Deoxycytidine/adverse effects, Deoxycytidine/analogs & derivatives, Deoxycytidine/therapeutic use, Disease Progression, Disease-Free Survival, Erlotinib Hydrochloride, Female, Gallbladder Neoplasms/drug therapy, Gallbladder Neoplasms/epidemiology, Gallbladder Neoplasms/pathology, Humans, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Organoplatinum Compounds/administration & dosage, Organoplatinum Compounds/adverse effects, Organoplatinum Compounds/therapeutic use, Quinazolines/administration & dosage, Quinazolines/adverse effects

Relation: LANCET ONCOLOGY; J02154; OAK-2012-00477; https://ir.ymlib.yonsei.ac.kr/handle/22282913/91384; http://www.sciencedirect.com/science/article/pii/S1470204511703011; T201200697; LANCET ONCOLOGY, Vol.13(2) : 181-188, 2012

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/91384
http://www.sciencedirect.com/science/article/pii/S1470204511703011

المساهمون: Chung M.J., Kim Y.J., Park J.Y., Bang S., Song S.Y., Chung J.B., Park S.W., Park, Jeong Youp, Bang, Seung Min, Song, Si Young, Chung, Moon Jae, Chung, Jae Bock, Kim, Yoon Jae, Park, Seung Woo

مصطلحات موضوعية: Adult, Aged, Alanine Transaminase/metabolism, Anemia/etiology, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Aspartate Aminotransferases/metabolism, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/mortality, Biliary Tract Neoplasms/pathology, Camptothecin/administration & dosage, Camptothecin/analogs & derivatives, Camptothecin/therapeutic use, Deoxycytidine/administration & dosage, Deoxycytidine/analogs & derivatives, Deoxycytidine/therapeutic use, Female, Humans, Male, Middle Aged, Neutropenia/etiology, Positron-Emission Tomography, Survival Rate, Thrombocytopenia/etiology, Tomography, X-Ray Computed, Biliary tract cancer, Chemotherapy, GemcitabineIrinotecan

وصف الملف: 236~243

Relation: CHEMOTHERAPY; J00519; OAK-2011-00751; https://ir.ymlib.yonsei.ac.kr/handle/22282913/93277; http://www.karger.com/Article/FullText/328021; T201101490; CHEMOTHERAPY, Vol.57(3) : 236-243, 2011

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/93277
https://doi.org/10.1159/000328021
http://www.karger.com/Article/FullText/328021

المساهمون: Jae Yun Lim, Hei-Cheul Jeung, Hee Sun Mun, Dong Ki Lee, Yong Han Paik, Se Joon Lee, Dong Sup Yoon, Jae Yong Cho, Yoon, Dong Sup, Lee, Dong Ki, Lee, Se Joon, Lim, Jae Yun, Jeung, Hei Cheul, Cho, Jae Yong, Mun, Hee Sun, Paik, Yong Han

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/mortality, Biliary Tract Neoplasms/pathology, Female, Fluorouracil/administration & dosage, Humans, Leucovorin/administration & dosage, Male, Middle Aged, Neoplasm Metastasis, Neoplasm Recurrence, Local/drug therapy, Local/mortality, Organoplatinum Compounds/administration & dosage, Oxaliplatin

وصف الملف: 631~635

Relation: ANTI-CANCER DRUGS; J00187; OAK-2008-02509; https://ir.ymlib.yonsei.ac.kr/handle/22282913/108629; http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00001813-200807000-00010&LSLINK=80&D=ovft; T200806170; ANTI-CANCER DRUGS, Vol.19(6) : 631-635, 2008

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/108629
https://doi.org/10.1097/CAD.0b013e3283017f94
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&AN=00001813-200807000-00010&LSLINK=80&D=ovft

المؤلفون: Kim, Kyubo, Chie, Eui Kyu, Jang, Jin-Young, Kim, Sun Whe, Oh, Do-Youn, Im, Seock-Ah, Kim, Tae-You, Bang, Yung-Jue, Ha, Sung W

المساهمون: 김규보, 지의규, 장진영, 김선희, 오도윤, 임석아, 김태유, 방영주

مصطلحات موضوعية: Adult, Aged, Antiemetics/*therapeutic use, Benzimidazoles/*therapeutic use, Biliary Tract Neoplasms/*drug therapy, Chemotherapy, Adjuvant/*adverse effects, Female, Fluorouracil/*administration &, dosage, Humans, Male, Metoclopramide/therapeutic use, Middle Aged, Nausea/physiopathology/*prevention &, control, Ondansetron/therapeutic use, Pancreatic Neoplasms/*drug therapy, Radiotherapy, Vomiting/physiopathology/*prevention &

Relation: Jpn J Clin Oncol. 2009 Feb;39(2):111-5. Epub 2008 Dec 5.; 1465-3621 (Electronic); http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19060294; http://jjco.oxfordjournals.org/cgi/reprint/39/2/111.pdf; http://hdl.handle.net/10371/46133

الاتاحة: http://hdl.handle.net/10371/46133
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=19060294
http://jjco.oxfordjournals.org/cgi/reprint/39/2/111.pdf
https://doi.org/10.1093/jjco/hyn140

المؤلفون: Lee, Jeeyun, Kim, Tae-You, Lee, Myung Ah, Ahn, Myung Ju, Kim, Hoon-Kyo, Lim, Ho Yeong, Lee, Nam Su, Park, Byung Joo, Kim, Jun Suk

المساهمون: 이지연, 김태유, 이명아, 안명주, 김훈규, 임호영, 이남수, 박병주, 김준석

مصطلحات موضوعية: Adenocarcinoma/*drug therapy/pathology, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use, Biliary Tract Neoplasms/*drug therapy/pathology, Cisplatin/administration &, dosage, Deoxycytidine/administration &, dosage/analogs &, derivatives, Disease Progression, Female, Humans, Infusions, Intravenous, Liver Neoplasms/secondary, Male, Middle Aged, Nausea/chemically induced, Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasm Staging, Survival Rate, Treatment Outcome, Vomiting/chemically induced

Relation: Cancer Chemother Pharmacol. 2008 ;61(1):47-52.; 0344-5704 (Print); http://hdl.handle.net/10371/62992

الاتاحة: http://hdl.handle.net/10371/62992
https://doi.org/10.1007/s00280-007-0444-5

المساهمون: Byung Kyu Park, Yoon Jae Kim, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Jae Bock Chung, Kyung Sik Kim, Jin-Sub Choi, Woo Jung Lee, Si Young Song, Kim, Kyung Sik, Kim, Yoon Jae, Park, Byung Kyu, Park, Seung Woo, Park, Jeong Youp, Bang, Seung Min, Song, Si Young, Lee, Woo Jung, Chung, Jae Bock, Choi, Jin Sub

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Biliary Tract Neoplasms/drug therapy, Cisplatin/administration & dosage, Deoxycytidine/administration & dosage, Deoxycytidine/analogs & derivatives, Female, Humans, Male, Middle Aged, Treatment Outcome, biliary tract cancer, chemotherapy, cisplatin, gemcitabine

وصف الملف: 999~1003

Relation: JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY; J01417; OAK-2006-01120; https://ir.ymlib.yonsei.ac.kr/handle/22282913/109860; T200600911; JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.21(6) : 999-1003, 2006

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/109860
https://doi.org/10.1111/j.1440-1746.2006.04230.x
http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1746.2006.04230.x/abstract

المساهمون: Jae Yong Cho, Yong Han Paik, Yoon Soo Chang, Se Joon Lee, Dong-Ki Lee, Si Young Song, Jae Bock Chung, Mi-Suk Park, Jeong-Sik Yu, Dong-Sup Yoon, Park, Mi Sook, Paik, Yong Han, Song, Si Young, Yu, Jeong Sik, Yoon, Dong Sup, Lee, Dong Ki, Lee, Se Joon, Jang, Yang Soo, Chung, Jae Bock, Cho, Jae Yong

مصطلحات موضوعية: Adult, Aged, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Biliary Tract Neoplasms/drug therapy, Biliary Tract Neoplasms/mortality, Biliary Tract Neoplasms/pathology, Biopsy, Needle, Bone Neoplasms/secondary, Capecitabine, Carcinoma, Ductal/drug therapy, Ductal/secondary, Deoxycytidine/administration & dosage, Deoxycytidine/analogs & derivatives, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Fluorouracil/analogs & derivatives, Humans, Immunohistochemistry, Liver Neoplasms/secondary, Lung Neoplasms/secondary, Lymphatic Metastasis, Male, Maximum Tolerated Dose, Middle Aged, Neoplasm Staging

Relation: CANCER; J00434; OAK-2005-13355; https://ir.ymlib.yonsei.ac.kr/handle/22282913/151239; T200501167; CANCER, Vol.104(12) : 2753-2758, 2005; 43961

الاتاحة: https://ir.ymlib.yonsei.ac.kr/handle/22282913/151239
https://doi.org/10.1002/cncr.21591

المؤلفون: Edeline, Julien, Benabdelghani, Meher, Bertaut, Aurélie, Watelet, Jérôme, Hammel, Pascal, Joly, Jean-Paul, Boudjema, Karim, Fartoux, Laetitia, Bouhier-Leporrier, Karine, Jouve, Jean-Louis, Faroux, Roger, Guerin-Meyer, Véronique, Kurtz, Jean-Emmanuel, Assenat, Eric, Seitz, Jean-Francois, Baumgaertner, Isabelle, Tougeron, David, de La Fouchardiere, Christelle, Lombard-Bohas, Catherine, Boucher, Eveline, Stanbury, Trevor, Louvet, Christophe, Malka, David, Phélip, Jean-Marc

المساهمون: CRLCC Eugène Marquis (CRLCC), UNICANCER, Centre Paul Strauss (CRLCC Paul Strauss), Centre Régional de Lutte contre le cancer Georges-François Leclerc Dijon (UNICANCER/CRLCC-CGFL), Service d'Hépato-gastro-entérologie CHRU Nancy, Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Amiens-Picardie, Centre Hospitalier Universitaire de Rennes CHU Rennes = Rennes University Hospital Pontchaillou, CHU Saint-Antoine AP-HP, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Hôpital Côte de Nacre CHU Caen, CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hôpital du Bocage, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon (CHD Vendée), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Service d'oncologie digestive et hépato-gastro-entérologie Hôpital de la Timone - APHM, Assistance Publique - Hôpitaux de Marseille (APHM)-Hôpital de la Timone CHU - APHM (TIMONE), Service d'Oncologie médicale CHU Henri Mondor, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor Créteil, Centre hospitalier universitaire de Poitiers = Poitiers University Hospital (CHU de Poitiers La Milétrie ), Centre Léon Bérard Lyon, Hôpital Edouard Herriot CHU - HCL, Hospices Civils de Lyon (HCL), UNICANCER Paris, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut Mutualiste de Montsouris (IMM), Institut Gustave Roussy (IGR), Département de médecine oncologique Gustave Roussy, Service de Gastro-entérologie et Hépatologie CHU Saint-Etienne, Centre Hospitalier Universitaire de Saint-Etienne CHU Saint-Etienne (CHU ST-E)

المصدر: ISSN: 0732-183X.

مصطلحات موضوعية: MESH: Antineoplastic Combinated Chemotherapy Protocol / therapeutic uses, Biliary Tract Neoplasms / drug therapy, Biliary Tract Neoplasms / surgery, Deoxycytidine / analogs & derivatives, Oxaliplatin / administration & dosage, Watchful waiting, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences

الاتاحة: https://hal.umontpellier.fr/hal-02922781
https://doi.org/10.1200/JCO.18.00050

المؤلفون: Jean-Paul Joly, Eric Assenat, Veronique Guerin-Meyer, Aurélie Bertaut, Jean-Louis Jouve, Jérôme Watelet, Christelle De La Fouchardiere, Catherine Lombard-Bohas, Trevor Stanbury, Karim Boudjema, Eveline Boucher, Laetitia Fartoux, Jean-Marc Phelip, Pascal Hammel, Jean-François Seitz, Karine Bouhier-Leporrier, Jean-Emmanuel Kurtz, M. Benabdelghani, Isabelle Baumgaertner, David Malka, David Tougeron, Roger Faroux, Julien Edeline, Christophe Louvet

المساهمون: Centre Eugène Marquis (CRLCC), Centre Paul Strauss, CRLCC Paul Strauss, Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER, Service d'Hépato-gastro-entérologie [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Hôpital Beaujon, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Amiens-Picardie, CHU Pontchaillou [Rennes], Service d'Oncologie Médicale [CHU Saint -Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Hôpital Côte de Nacre [CHU Caen], CHU Caen, Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN)-Normandie Université (NU)-Tumorothèque de Caen Basse-Normandie (TCBN), Hôpital du Bocage, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre Hospitalier Départemental - Hôpital de La Roche-sur-Yon, Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), CHU Strasbourg, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Service d'oncologie digestive et hépato-gastro-entérologie [Hôpital de la Timone - APHM], Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE), Service d'Oncologie médicale [CHU Henri Mondor], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Henri Mondor, Centre hospitalier universitaire de Poitiers (CHU Poitiers), Centre Léon Bérard [Lyon], Hôpital Edouard Herriot [CHU - HCL], Hospices Civils de Lyon (HCL), UNICANCER [Paris], Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Institut Mutualiste de Montsouris (IMM), Institut Gustave Roussy (IGR), Département de médecine oncologique [Gustave Roussy], Service de gastroentérologie [CHU Saint-Etienne], Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne)

المصدر: Journal of Clinical Oncology
Journal of Clinical Oncology, American Society of Clinical Oncology, 2019, 37 (8), pp.658-667. ⟨10.1200/JCO.18.00050⟩

مصطلحات موضوعية: Adult, Male, Cancer Research, medicine.medical_specialty, Time Factors, medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, Gastroenterology, MESH: Antineoplastic Combinated Chemotherapy Protocol / therapeutic uses, Biliary Tract Neoplasms / drug therapy, Biliary Tract Neoplasms / surgery, Deoxycytidine / analogs & derivatives, Oxaliplatin / administration & dosage, Watchful waiting, Deoxycytidine, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Progression-free survival, Watchful Waiting, Aged, Aged, 80 and over, Chemotherapy, Biliary tract cancer, business.industry, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences, Middle Aged, Gemcitabine, Progression-Free Survival, 3. Good health, Oxaliplatin, Clinical trial, Biliary Tract Surgical Procedures, Biliary Tract Neoplasms, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Quality of Life, 030211 gastroenterology & hepatology, Female, France, business, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0be4c2f1e0b39ec3fe3e2e0119457bf
https://pubmed.ncbi.nlm.nih.gov/30707660

المؤلفون: Larsen, Finn Ole, Markussen, Alice, Diness, Laura V, Nielsen, Dorte

المصدر: Larsen , F O , Markussen , A , Diness , L V & Nielsen , D 2018 , ' Efficacy and Safety of Capecitabine, Irinotecan, Gemcitabine, and Bevacizumab as Second-Line Treatment in Advanced Biliary Tract Cancer : A Phase II Study ' , Oncology , vol. 94 , no. 1 , pp. 19-24 . https://doi.org/10.1159/000479970

مصطلحات موضوعية: Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Bevacizumab/administration & dosage, Biliary Tract Neoplasms/drug therapy, Camptothecin/administration & dosage, Capecitabine/administration & dosage, Deoxycytidine/administration & dosage, Disease-Free Survival, Female, Humans, Irinotecan, Male, Middle Aged, Organoplatinum Compounds/administration & dosage, Prospective Studies

الاتاحة: https://researchprofiles.ku.dk/da/publications/efficacy-and-safety-of-capecitabine-irinotecan-gemcitabine-and-bevacizumab-as-secondline-treatment-in-advanced-biliary-tract-cancer(bf42e3af-0cd2-446e-9bc3-643ca2f1ea30).html
https://doi.org/10.1159/000479970